MOTS-C is a chain of 16 amino acids (sequence MRWQEMGYIFYPRKLR). An identity fact, not a product claim.
Lee et al., Cell Metabolism, 2015Plain-English research guideMOTS-C / MT-RNR1 sORF
MOTS-C research guide
Everything worth knowing, without the jargon.
MOTS-C is a 16-amino-acid mitochondrial-derived peptide (MDP) - one of a small family of peptides encoded inside mitochondrial DNA, in the 12S rRNA (MT-RNR1) region. First described in 2015, it's studied in cell and animal research for mitochondrial biology and the AMPK energy pathway.
Form Labs materials are research reference materials, not the approved medicines; no Form Labs product is approved for human or veterinary use.
REV 2026-10 · 1 Oct 20265 peer-reviewed studiesResearch-use-only context
What the papers reportThird-party literature - not product claims
The year MOTS-C was first described, as one of a small family of peptides encoded inside mitochondrial DNA. Research context, not a product claim.
Lee et al., Cell Metabolism, 2015The cell's main energy-sensing pathway (AMP-activated protein kinase) - the pathway MOTS-C is most associated with across the research. Research context, not a product claim.
Lee et al., Cell Metabolism, 2015Why it matters
Why is MOTS-C studied?
MOTS-C is studied because it is a 16-amino-acid mitochondrial-derived peptide (MDP) encoded inside mitochondrial DNA in the 12S rRNA (MT-RNR1) region rather than in the cell nucleus (Form Labs catalogue record). Lee and colleagues first described MOTS-C in 2015 (Lee et al., Cell Metabolism, 2015). Most of the research cited in this guide is cell-culture and rodent work on mitochondrial biology and the AMPK energy pathway, and none of it gave native MOTS-C to people.
A peptide written in mitochondrial DNA.
Nearly every protein the body makes is encoded in the DNA inside the cell's nucleus. MOTS-C is unusual because its gene sits inside mitochondrial DNA - the small, separate genome of the mitochondria themselves, the energy-handling structures inside the cell. That's what first drew researchers to it.
It was first described in 2015 by Lee and colleagues, who identified it from a short open reading frame in the mitochondrial 12S rRNA gene (the MT-RNR1 region). That made it one of a small, newly recognised family of mitochondrial-derived peptides - humanin is another - and the field is still young.
Most of what's been published since is cell-culture and rodent research into mitochondrial biology and the AMPK energy pathway. There are no large human trials of the native peptide, so this guide treats all of it as research context - not as anything the vial will do for a person.
Study observations
What laboratory observations have MOTS-C studies reported?
Lee et al. (Cell Metabolism, 2015) reported AMPK-pathway and insulin-sensitivity observations for MOTS-C in cell and mouse models, with no human data. Kim et al. (Cell Metabolism, 2018) reported MOTS-C movement into the nucleus under glucose restriction in cultured human cells. Cell-culture findings remain distinct from a clinical study in people.
MOTS-C laboratory observations Findings stay tied to the cited study and its model.
Mitochondrial origin
Lee et al. (Cell Metabolism, 2015) described MOTS-C as a mitochondrial-derived peptide in cell and mouse research.
Cell and mouse models
Lee et al. (Cell Metabolism, 2015) linked MOTS-C to the folate/one-carbon and AMPK pathways in cell and mouse models; the paper included no human data.
Cultured human cells
Kim et al. (Cell Metabolism, 2018) reported MOTS-C movement into the nucleus under glucose restriction in cultured human cells; this is a cell-culture finding.
Pharmacology at a glance
- Research code
- MOTS-C / MT-RNR1 sORF
- Class
- Mitochondrial-derived peptide (MDP) - a small peptide encoded inside mitochondrial DNA rather than the cell nucleus.
- Molecule
- A 16-amino-acid peptide, sequence MRWQEMGYIFYPRKLR, supplied as a freeze-dried powder.
- Reported half-life
- This guide records no established clinical half-life for MOTS-C.
- Originator
- First described by Lee and colleagues in 2015, from a short open reading frame in the mitochondrial 12S rRNA gene. Form Labs did not run the cited studies.
- Approval status
- Laboratory research material only - not an approved medicine, and not evaluated by the TGA or any regulator for human use.
What it has been studied for
What has MOTS-C been studied for?
MOTS-C research includes cell and mouse metabolism findings (Lee et al., Cell Metabolism, 2015), cultured-cell stress observations (Kim et al., Cell Metabolism, 2018), and exercise-related measurements in mice and healthy men (Reynolds et al., Nature Communications, 2021). The human observations measured endogenous MOTS-C rather than a clinical intervention with native MOTS-C.
Study areas from the published literature.
Metabolic homeostasis & AMPK
Activation of the AMPK energy-sensing pathway via folate/one-carbon metabolism, and insulin sensitivity in mice.
Lee et al., Cell Metabolism, 2015 (cells + mice)Mitonuclear stress signalling
Movement of MOTS-C into the nucleus under glucose restriction to regulate stress-response genes.
Kim et al., Cell Metabolism, 2018 (cells)Exercise & age-related physical decline
Running capacity and physical performance in aged mice; one cycling bout raised endogenous MOTS-C in 10 healthy men.
Reynolds et al., Nature Communications, 2021 (mice + human exercise)Muscle function & CK2 (genetic association)
Binding and activation of CK2 in mice and cells, and a natural gene variant linked to sarcopenia and type-2-diabetes risk across three human cohorts.
Kumagai et al., iScience, 2024 (mice + cells + human genetic)Circulating MOTS-C as a biomarker
Blood levels of MOTS-C measured against obesity and insulin-resistance markers in young people.
Du et al., Pediatric Diabetes, 2018 (human observational)The studies
What did the MOTS-C studies find?
The five MOTS-C studies cited in this guide are mostly cell and mouse work, with human data that is observational. Lee et al. (Cell Metabolism, 2015) reported that MOTS-C activated AMPK and was associated with improved insulin sensitivity in mice, with no human data. Reynolds et al. (Nature Communications, 2021) found one cycling bout raised the body's own MOTS-C in 10 healthy men. Du et al. (Pediatric Diabetes, 2018) found circulating MOTS-C was lower in obese than non-obese children.
Open any study for a plain summary, what it measured, the finding, and a link to the paper.
The paper that first identified MOTS-C, from a short open reading frame in mitochondrial DNA, and linked it to the AMPK energy pathway and insulin sensitivity in mice.
- Studied in
- Human cell lines (HEK293, HeLa, L6) and mice.
- Design
- A discovery paper - lab cell work plus animal experiments that established the peptide and its main pathway.
- Measured
- AMPK pathway activation, folate/one-carbon metabolism, and markers of insulin sensitivity in mice.
Lee et al. (Cell Metabolism, 2015) reported AMPK activation through the folate/one-carbon pathway in cells and increased insulin sensitivity in mice. The paper included no human data.
DOI 10.1016/j.cmet.2015.02.009This paper showed that under glucose restriction MOTS-C moves into the cell nucleus and helps regulate stress-response genes.
- Studied in
- Human cell lines (HEK293, HepG2) in culture.
- Design
- A cell-culture study of where MOTS-C sits in the cell and which genes it touches under metabolic stress.
- Measured
- Movement of MOTS-C into the nucleus and changes in stress- and antioxidant-response gene activity (NRF2/AMPK).
Under glucose restriction, MOTS-C moved from the cytoplasm into the nucleus of the cultured cells and helped regulate antioxidant and stress-response genes (Kim KH, Son JM, Benayoun BA, Lee C - Cell Metabolism - 2018).
DOI 10.1016/j.cmet.2018.06.008This paper reported that aged mice given MOTS-C had better physical performance, and that one bout of cycling raised the body's own MOTS-C in 10 healthy men.
- Studied in
- Aged mice, plus 10 healthy men for an endogenous (body's-own) measurement.
- Design
- Animal experiments on running capacity, grip and stride, plus a small human exercise observation. No MOTS-C was given to the men.
- Measured
- Running capacity, grip strength and stride in aged mice; endogenous MOTS-C levels after exercise in the men; and lifespan in mice.
Reynolds et al. (Nature Communications, 2021) reported running-capacity, grip and stride differences in aged mice. Separately, endogenous MOTS-C rose after cycling in 10 healthy men; the men did not receive MOTS-C. The mouse lifespan trend was non-significant (P=0.05).
DOI 10.1038/s41467-020-20790-0This paper reported that MOTS-C binds and activates a protein called CK2, and that a natural gene variant with weaker CK2 binding was linked to certain muscle and metabolic traits in large human cohorts.
- Studied in
- Mice and cell cultures, plus three human cohort datasets analysed for a genetic association.
- Design
- Lab mechanistic work on CK2 binding plus a genetic-association analysis of a natural MOTS-C variant. Not a trial that gave MOTS-C to people.
- Measured
- CK2 binding and activation in mice and cells; and statistical association of the K14Q variant with sarcopenia and type-2-diabetes risk across the cohorts.
MOTS-C bound and activated CK2 in mice and cells (Kumagai H, Kim SJ, Miller B, et al. - iScience - 2024). A natural MOTS-C gene variant (K14Q) with weaker CK2 binding was associated, across three human cohorts, with higher sarcopenia and type-2-diabetes risk (Kumagai H, Kim SJ, Miller B, et al. - iScience - 2024). This is a genetic association rather than a clinical outcome for native MOTS-C (Kumagai H, Kim SJ, Miller B, et al. - iScience - 2024).
DOI 10.1016/j.isci.2024.111212This paper measured MOTS-C in the blood of young people and compared the levels across obesity and insulin-resistance groups.
- Studied in
- Children and adolescents, grouped by obesity status.
- Design
- An observational biomarker study - measuring circulating MOTS-C and comparing it across groups. No MOTS-C was given to anyone.
- Measured
- Blood levels of MOTS-C alongside insulin-resistance and related metabolic markers.
Circulating MOTS-C was lower in obese than non-obese children and adolescents (a human observational measurement), and tracked with insulin-resistance markers (Du C, Zhang C, Wu W, et al. - Pediatric Diabetes - 2018). It's an observational study in people, not a trial that gave MOTS-C to anyone - a correlation in a population, not evidence of what the peptide does to a person (Du C, Zhang C, Wu W, et al. - Pediatric Diabetes - 2018).
DOI 10.1111/pedi.12685Where evidence stops
What has MOTS-C research not established?
MOTS-C research cited in this guide has not included large human clinical trials: none of the cited studies gave native MOTS-C to people for any outcome. Human efficacy numbers are not established in the cited literature. The research cited in this guide gives no direction for use in or on people or animals, and describes the molecule in general, not what a specific batch does.
- Large human clinical trials - there is no peer-reviewed trial giving native MOTS-C to people for any outcome.
- Any use in or on people or animals - none of the research on this page is a use direction.
- What a specific batch does - the studies are about the molecule in general, not this vial.
Development and status
Is MOTS-C approved, and where does the research stand?
MOTS-C is described in this guide as laboratory research material only. This guide's timeline begins with Lee and colleagues' description of MOTS-C (Lee et al., Cell Metabolism, 2015), then nuclear movement under glucose restriction (Kim et al., Cell Metabolism, 2018), mouse and exercise data (Reynolds et al., Nature Communications, 2021) and CK2 binding (Kumagai et al., iScience, 2024).
MOTS-C is first described by Lee and colleagues, from a short open reading frame in mitochondrial DNA (Cell Metabolism).
Kim and colleagues report MOTS-C moving into the nucleus under glucose restriction to regulate stress-response genes (Cell Metabolism).
Du and colleagues measure circulating MOTS-C against obesity and insulin-resistance markers in young people (Pediatric Diabetes).
Reynolds and colleagues report better physical performance in aged mice given MOTS-C, and that exercise raises the body's own MOTS-C in 10 healthy men (Nature Communications).
Kumagai and colleagues map CK2 binding and activation, and a linked natural gene variant associated with muscle and metabolic traits (iScience).
Approval status: Laboratory research material only - not an approved medicine, and not evaluated by the TGA or any regulator for human use.Whatever the molecule’s status elsewhere, what Form Labs supplies is research-use-only reference material - for laboratory work, not for people or animals.
Evidence and limitations
What does the MOTS-C research mean, and what does it not?
The MOTS-C evidence comes from a young field: MOTS-C was first described in 2015 (Lee et al., Cell Metabolism, 2015), and the research cited in this guide is predominantly cell cultures and mice, which does not translate into claims about people. The human-linked findings are observational or endogenous, covering exercise raising the body's own MOTS-C, a gene variant associated with traits, and blood levels tracking markers. None gave MOTS-C to people as a treatment.
It's a young field
MOTS-C was first described in 2015, and mitochondrial-derived peptides as a family are still new. The evidence base is growing but small compared with longer-studied peptides.
Most evidence is cells and rodents
The published work is predominantly cell cultures and mice. Useful for understanding the molecule, but it doesn't translate into claims about people.
The human evidence is observational only
The human-linked findings are observational or endogenous - exercise raises the body's own MOTS-C (Reynolds), a gene variant is associated with traits (Kumagai), and blood levels track markers (Du). None gave MOTS-C to people as a treatment.
The lab report is the authority for a batch
Historical sample reports and these papers do not establish current lot identity, purity or release status.
Lab handling
How is MOTS-C handled as reference material?
MOTS-C is laboratory reference material, not for human consumption or veterinary use. Storage and lot checks follow the product label and any verified matching certificate of analysis (COA). This guide's catalogue record notes storage at 2-8 C and protection from light. Historical sample reports do not verify current lot identity, purity or release status.
Research-use boundary
MOTS-C is supplied strictly for laboratory research. It's not for human consumption, veterinary, medical, or cosmetic use.
COA and label
The historical report on file for MOTS-C is an independent lab assessment measuring peptide content at 11.15 mg; it prints no purity percentage. It covers its named sample, not the current catalog lot. Matching current certification is unverified.
Storage
Supplied freeze-dried. Store cold at 2-8 C (fridge-cold) and out of light, following the vial label, any verified matching lab report for the batch, and the receiving lab's own written procedures.
Educational boundary
This guide is a plain summary of third-party research that Form Labs did not run. It isn't medical advice or a product claim.
Glossary
Plain-English definitions.
- Mitochondrial-derived peptide (MDP)
- A small peptide encoded inside mitochondrial DNA rather than the cell's nuclear DNA. MOTS-C and humanin are examples.
- MT-RNR1
- The mitochondrial gene region that codes for the 12S rRNA, where MOTS-C's short gene sits.
- 12S rRNA
- A type of ribosomal RNA encoded by mitochondrial DNA; produced by the MT-RNR1 gene.
- sORF
- Short open reading frame - a short genetic section that can code for a small peptide, like MOTS-C.
- AMPK
- AMP-activated protein kinase - the cell's central energy-sensing pathway, and the one MOTS-C is most associated with.
- Folate / one-carbon (AICAR) pathway
- A metabolic route the 2015 paper linked to MOTS-C's activation of AMPK.
- Mitonuclear
- Describing communication between the mitochondria and the cell nucleus - relevant to MOTS-C's move into the nucleus under stress.
- CK2
- A protein kinase (enzyme) that MOTS-C binds and activates, as reported in 2024 lab work.
- GLUT4
- A transport protein that moves glucose across cell membranes; named in MOTS-C study context.
- RUO
- Research use only - a lab-only boundary, not for human consumption, veterinary, medical, or cosmetic use.
- COA
- Certificate of analysis - the batch paperwork controlling identity, purity, appearance, and release.
FAQ
What are the most common questions about MOTS-C?
MOTS-C is a 16-amino-acid mitochondrial-derived peptide with the sequence MRWQEMGYIFYPRKLR, encoded in the 12S rRNA (MT-RNR1) region of mitochondrial DNA (Form Labs catalogue record). The most common questions about MOTS-C cover what a mitochondrial-derived peptide is, what the discovery paper found (Lee et al., Cell Metabolism, 2015), whether human trials exist, how MOTS-C relates to AMPK, exercise and aging, and how it differs from humanin. Form Labs supplies research-use-only reference material.
MOTS-C is a 16-amino-acid mitochondrial-derived peptide (sequence MRWQEMGYIFYPRKLR) encoded within the 12S rRNA (MT-RNR1) region of mitochondrial DNA, studied in cell and animal research for mitochondrial biology and the AMPK energy pathway.
A mitochondrial-derived peptide (MDP) is a small peptide encoded inside mitochondrial DNA rather than the cell nucleus. MOTS-C was first described in 2015 by Lee and colleagues in Cell Metabolism, from a short open reading frame in the mitochondrial 12S rRNA gene; it's one of a small MDP family that also includes humanin.
Lee et al. (Cell Metabolism, 2015) reported AMPK-pathway observations in cells and increased insulin sensitivity in mice; the paper included no human data.
Reynolds et al. (Nature Communications, 2021) measured endogenous MOTS-C after cycling in 10 healthy men. Kumagai et al. (iScience, 2024) reported genetic associations, and Du et al. (Pediatric Diabetes, 2018) reported circulating MOTS-C measurements. These are observational or genetic records rather than clinical intervention results for native MOTS-C.
Lee et al. (Cell Metabolism, 2015) reported a link between MOTS-C, folate/one-carbon metabolism and AMPK in cell and mouse models; the study included no human data.
Reynolds et al. (Nature Communications, 2021) reported running-capacity and physical-performance differences in aged mice. In a separate observation, endogenous MOTS-C rose after cycling in 10 healthy men, who did not receive MOTS-C. The lifespan trend in mice was non-significant; the animal and human observations remain distinct.
Kim and colleagues (2018) reported that, under glucose restriction, MOTS-C moves from the cytoplasm into the cell nucleus and helps regulate stress- and antioxidant-response genes (via NRF2/AMPK). This was a cell-culture study in human cell lines, describing how the peptide behaves in cells under stress - not a human or animal outcome.
No. MOTS-C and humanin are both mitochondrial-derived peptides, but they're different molecules encoded by different parts of mitochondrial DNA (MOTS-C from the 12S rRNA / MT-RNR1 region) and studied for overlapping but distinct roles in metabolism and stress signalling. MOTS-C is a 16-amino-acid peptide, sequence MRWQEMGYIFYPRKLR.
"For research use only" means MOTS-C is supplied strictly for laboratory research and is not for human or veterinary consumption, medical use, or cosmetic use. This guide is an educational summary of third-party published research that Form Labs did not conduct - not medical advice or a product claim.
MOTS-C acts on the AMPK pathway, and the World Anti-Doping Agency (WADA) prohibits AMPK activators as metabolic modulators (category S4) at all times in sport. Athletes subject to anti-doping rules should confirm MOTS-C's current status directly with WADA. Form Labs supplies MOTS-C for laboratory research only, not for human use.
References
Every figure, sourced.
Educational references to third-party literature. Form Labs is unaffiliated with the study authors.
The 2015 discovery paper identifying MOTS-C and linking it to the AMPK pathway and insulin sensitivity in mice. Lee C, Zeng J, Drew BG, et al. Cell Metabolism, 2015.
DOICell-culture study of MOTS-C moving into the nucleus under glucose restriction to regulate stress-response genes. Kim KH, Son JM, Benayoun BA, Lee C. Cell Metabolism, 2018.
DOIMouse and small human exercise study of MOTS-C, physical performance and aging. Reynolds JC, Lai RW, Woodhead JST, et al. Nature Communications, 2021; 12: 470.
DOIMouse, cell and human genetic-association study linking MOTS-C to CK2 binding and to muscle and metabolic traits. Kumagai H, Kim SJ, Miller B, et al. iScience, 2024; 27: 111212.
DOIHuman observational study of circulating MOTS-C against obesity and insulin-resistance markers in young people. Du C, Zhang C, Wu W, et al. Pediatric Diabetes, 2018.
DOIReview of MOTS-C as a mitochondrial-derived peptide regulating muscle and fat metabolism. Lee C, Kim KH, Cohen P. Free Radical Biology and Medicine, 2016.
DOIReview of mitochondrial-derived peptides in aging and age-related disease. Kim et al. The Journal of Physiology, 2017.
DOIReview of MOTS-C as a candidate for metabolic disorders. Wan et al. Journal of Translational Medicine, 2023.
DOIReview of MOTS-C in metabolic homeostasis and longevity. Mohtashami et al. International Journal of Molecular Sciences, 2022.
DOIReview of the role of MOTS-C in metabolic diseases. Zheng et al. Frontiers in Endocrinology, 2023.
DOICitations are provided for education only. No therapeutic, weight-loss, or efficacy claims are made.
How we produce these guides
These guides are written and maintained in-house by the Form Laboratories research team. They summarise published literature and link to the cited papers. Form Laboratories did not run those studies. They are not authored by a named clinician and are not medical advice.
Findings remain tied to the study population, model and limits. Cell and animal observations remain separate from clinical results. Everything we supply is research-use-only reference material, not for people or animals.
The product
Form Laboratories - MOTS-C
Ready to see MOTS-C?
- Check available reports and the tests they cover.
- Compare the listed compound, amount and lot with the report.
- Ships from Perth via Australia Post or CouriersPlease in plain packaging.
Related catalogue records
Compare nearby catalogue records.
These nearby records stay inside the research-only catalogue.
Research-use-only catalogue
Continue to the product record.
Review lot-facing product details, pricing, and checkout boundaries on the matching product page.
View MOTS-C - from $99.00 AUD